Your browser doesn't support javascript.
loading
Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice.
Weycker, Derek; Li, Xiaoyan; Wygant, Gail DeVecchis; Lee, Theodore; Hamilton, Melissa; Luo, Xuemei; Vo, Lien; Mardekian, Jack; Pan, Xianying; Burns, Leah; Atwood, Mark; Hanau, Ahuva; Cohen, Alexander T.
Afiliação
  • Weycker D; Policy Analysis Inc. (PAI), Brookline, Massachusetts, United States.
  • Li X; Bristol-Myers Squibb, Lawrenceville, New Jersey, United States.
  • Wygant GD; Bristol-Myers Squibb, Lawrenceville, New Jersey, United States.
  • Lee T; Pfizer Inc., New York, New York, United States.
  • Hamilton M; Bristol-Myers Squibb, Lawrenceville, New Jersey, United States.
  • Luo X; Pfizer Inc., Groton, Connecticut, United States.
  • Vo L; Bristol-Myers Squibb, Lawrenceville, New Jersey, United States.
  • Mardekian J; Pfizer Inc., New York, New York, United States.
  • Pan X; Bristol-Myers Squibb, Wallingford, Connecticut, United States.
  • Burns L; Bristol-Myers Squibb, Lawrenceville, New Jersey, United States.
  • Atwood M; Policy Analysis Inc. (PAI), Brookline, Massachusetts, United States.
  • Hanau A; Policy Analysis Inc. (PAI), Brookline, Massachusetts, United States.
  • Cohen AT; Guy's and St. Thomas' Hospitals, London, United Kingdom.
Thromb Haemost ; 118(11): e1-e2, 2018 11.
Article em En | MEDLINE | ID: mdl-31986533
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article